Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2026-03-11 @ 5:24 PM
Study NCT ID:
NCT00100750
Status:
COMPLETED
Last Update Posted:
2015-01-13
First Post:
2005-01-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2009-00114
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None